Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
JinkoSolar to Report Second Quarter 2026 Results on August 26, 2026
-
Sigma Lithium Announces Record 2Q 26 Results: EBITDA Margin of 47%, Decrease of over 30% in Costs; TAC Agreement Negotiations Underway
-
Philz Coffee Strengthens Executive Leadership With Appointment of Mark Johnson as Chief Operating Officer - Retail
-
Prosafe SE: Invitation to webcast on Q2 and first half 2026 results on 28 August 2026
-
The Ultimate Guide to the Best Book Publicity Companies for 2026
-
Gdeal Releases Tribute Single “Ronaldo” Honoring the Soccer Icon
-
ITAR Compliance Training Takes on New Urgency for Defense Manufacturers Amid Increased State Department Scrutiny
-
MoneyFAQ Launches Free, Jargon-Free Financial Education Platform to Demystify Personal Finance for Everyone
-
From Stage Fright to Stage Delight: Former NATO Speechwriter Matthew Cossolotto Reveals the “Mental Joyjitsu” of Public Speaking
-
OUFER Body Jewelry Sponsors the 22nd Annual HollyShorts Film Festival, Bringing “Body Narrative” to the World of Cinema
-
Tenet Signs CAD$225M Minimum Guarantee Annual Services Agreement
-
V Ten Metals Announces Drill Program Update at the Tanami Property, NT, Australia
-
TuHURA Biosciences Reports Second Quarter 2026 Financial Results and Provides a Corporate Update
-
LanzaTech Reports Second Quarter 2026 Financial Results
-
SurgePays Reports Q2 2026 Revenue Growth of 40.7% Year-Over-Year to $16.2 Million, Reports Positive Net Income of $1.29 Million
-
Vital Infrastructure Property Trust Announces August 2026 Distribution
-
XAU Resources Provides Corporate Update on Quartzstone Transaction, Fortuna Exploration Program and Noseno Project
-
March to Abolish Animal Testing amplifies public call to end animal testing in the US
-
Kincora Reports June 2026 Quarterly Activities and Financial Results
-
Beneficient Reports First Quarter Fiscal 2027 Results
-
Edible Garden Reports Second Quarter 2026 Results; Revenue Grows 12.8%, Sales Increase 31.2% as Company Accelerates Farm-to-Formula® Strategy
-
Boost Run Inc. Reports First Earnings as a Public Company, Reporting Second Quarter 2026 Results, Supported by $1.9 Billion Total Contract Value
-
Lantern Pharma Reports Second Quarter 2026 Financial Results and Provides Business Update
-
U.S. Physical Therapy Announces CFO
-
Faeth Therapeutics Strengthens Executive Team with Senior Leadership Appointments
-
Canopy Growth Secures Renewed EU GMP Certification at Kincardine as European Medical Cannabis Business Grows
-
IQST - IQSTEL to Host Q2 2026 Earnings Call August 19 Following Record $207 Million First-Half Revenue as Company Enters EBITDA Expansion Phase
-
WRAP Selected by WOFT to Support Florida’s $475,000 Teacher Safety Training Initiative
-
Diginex Limited Announces Extraordinary General Meeting to Approve Proposed Acquisition of Resulticks
-
BridgeBio Pharma Announces Pricing of Oversubscribed Secondary Offering that Diversifies its Institutional Shareholder Base
-
Super League Reports Second Quarter 2026 Financial Results, Highlighted by Improving Margins and Operating Performance
-
Milestone Scientific Reports Financial Results for Second Quarter 2026
-
Base Carbon Reports Second-Quarter 2026 Operating and Financial Results
-
Applied Materials to Participate in Upcoming Investor Conferences
-
Helus Pharma Reports First Quarter Fiscal 2027 Financial Results and Recent Business Highlights
-
Boost Run Secures Long-Term Lease with 10X Capital to Expand GPU Compute Capacity
-
Investeringsforeningen ValueInvest Danmark – Indkaldelse til ekstraordinær generalforsamling
-
Jordn Announces New Single Gemini
-
DG Life Group Expands Dallas Life Insurance Focus as Local Families Seek More Personalized Financial Protection
-
36th Qingdao Int'l Beer Festival Ignites Summer Tourism Vitality
-
36th Qingdao Int'l Beer Festival Ignites Summer Tourism Vitality
-
Investeringsforeningen ValueInvest Danmark – Halvårsrapport 2026
-
Eucalyptus Resources Announces Submission of Four Highly Qualified Director Nominees at TNR Gold's Upcoming Annual Meeting
-
ProVen Growth and Income VCT plc: Director/PDMR Shareholding
-
Oksenholt Capital Challenges Pershing Square’s Discounted Freddie Mac Valuation
-
Outlook Therapeutics Reports Third Quarter Fiscal Year 2026 Financial Results and Provides Business Update Highlighting FDA Approval of LYTENAVA™
-
ProVen Growth and Income VCT plc: Issue of Equity
-
SouthGobi Announces Second Quarter 2026 Unaudited Financial and Operating Results
-
ProVen VCT plc: Director/PDMR Shareholding
-
Nagarro Management Board and Supervisory Board recommend the acceptance of the voluntary public takeover offer by Persistent
